Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.
Clinical trial NCT00316628 · COMPLETED
Trial details
- NCT number
- NCT00316628
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.